Transtibial Amputation Outcomes Study (TAOS)

Transtibial Amputation Outcomes Study (TAOS): Comparing Transtibial Amputation With (Ertl) and Without a Tibia-fibula Synostosis Procedure

The goals of the TAOS study is to determine the best procedures for below the knee amputations. There are two different procedures currently used by surgeons around the county: the Erlt procedure and the Burgess procedure. Proponents of the Ertl procedure advocate that the surgical formation of a tibia to fibula bone bridge provides stability, shape and weight bearing capability to the residual limb that result in less pain and better prosthetic fit and alignment. This procedure is popular especially among the military but it's advantages over the Burgess procedure are not well supported by current research. This study aims to compare the two amputation procedures in an adequately powered randomized trial.

Study Overview

Status

Completed

Detailed Description

High-energy open fractures, blast, gunshot wound and crush injuries to the distal tibia, ankle, hind foot and midfoot are common challenges to military and civilian trauma surgeons (Brown, 2009; Covey, 2002; Ficke, 2007; McGuigan, 2007; Hansen, 2001). Many surgeons believe that an early transtibial amputation provides a better long term functional outcome than limb salvage for these injuries (Hansen, 2001; Myerson, 1994; Sanders, 1992; Turchin,1999; Shawen, 2010;Ellington 2012). If a transtibial amputation is selected as the treatment for the patient, a controversy remains regarding the appropriate amputation technique. Many surgeons advocate for an amputation with a tibia-fibula synostosis technique (Ertl procedure) in young and active patients, believing that this procedure provides a better prosthetic interface, an end bearing capacity and soft tissue stability that improves performance and functional outcomes. (Pinto 2004; Pinzur 2006; Commuri 2010). Others strongly advocate for a standard posterior flap (Burgess procedure) without the synostosis, arguing that patients have similar outcomes with fewer complications and lower costs. (Pinzur 2008; Tindle 2011) To date, the outcomes of the transtibial amputation techniques have not been subjected to an appropriately powered prospective randomized clinical trial.

The primary study objective is to compare functional outcomes and number of revision surgeries to the amputated limb after first amputation for patients undergoing a transtibial amputation and randomized to receive a tibia-fibula synostosis (Ertl procedure) versus a standard posterior flap procedure (Burgess procedure).

The secondary study objectives are to compare levels of impairment for patients undergoing a transtibial amputation and randomized to receive a tibia-fibula synostosis (Ertl procedure) versus a standard posterior flap procedure (Burgess procedure); to compare levels of pain for patients undergoing a transtibial amputation and randomized to receive a tibia-fibula synostosis (Ertl procedure) versus a standard posterior flap procedure (Burgess procedure); and to compare initial hospitalization and overall treatment costs (through the 18 month follow-up) for patients undergoing a transtibial amputation and are randomized to receive a tibia-fibula synostosis (Ertl procedure) versus a standard posterior flap procedure (Burgess procedure). Patients who refuse randomization have the option of participating in a prospective observational study and the type of amputation is decided by the surgeon and patient.

Study Type

Interventional

Enrollment (Actual)

199

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94143
        • University of California San Francisco Medical Center
    • Florida
      • Miami, Florida, United States, 33136
        • University of Miami Ryder Trauma Center
      • Tampa, Florida, United States, 33606
        • Florida Orthopaedic Institute- Tampa General Hospital
    • Georgia
      • Atlanta, Georgia, United States, 30303
        • Emory University School of Medicine
    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Eskenazi Health
    • Iowa
      • Iowa City, Iowa, United States, 52242
        • University of Iowa Hospitals & Clinics
    • Maryland
      • Baltimore, Maryland, United States, 212101
        • University of Maryland/R Adams Cowley Shock Trauma Medical Center
      • Bethesda, Maryland, United States, 20889
        • Walter Reed National Military Medical Center
    • Minnesota
      • Minneapolis, Minnesota, United States, 55430
        • Hennepin County Medical Center
    • Mississippi
      • Jackson, Mississippi, United States, 39216
        • University of Mississippi Medical Center
    • Missouri
      • St Louis, Missouri, United States, 63110
        • Barnes Jewish Hospital
      • St Louis, Missouri, United States, 63110
        • St. Louis University Medical Center
    • North Carolina
      • Charlotte, North Carolina, United States, 28232
        • Carolinas Medical Center
      • Winston-Salem, North Carolina, United States, 27157
        • Wake Forest University Baptist Medical Center
    • Ohio
      • Cleveland, Ohio, United States, 44109
        • MetroHealth Medical Center
    • Oklahoma
      • Oklahoma City, Oklahoma, United States, 73104
        • University of Oklahoma
    • Pennsylvania
      • Hershey, Pennsylvania, United States, 17033
        • Penn State University M.S. Hershey Medical Center
      • Pittsburgh, Pennsylvania, United States, 15219
        • University of Pittsburgh Medical Center
    • Rhode Island
      • Providence, Rhode Island, United States, 02903
        • Rhode Island Hospital, Brown University
    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University Medical Center
    • Texas
      • Fort Sam Houston, Texas, United States, 78234-6315
        • San Antonio Miliary Medical Center
      • Houston, Texas, United States, 77030
        • UT Health: The University of Texas Health Science Center at Houston Medical School
    • Wisconsin
      • Madison, Wisconsin, United States, 53726
        • University of Wisconsin School of Medicine and Public Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients requiring a unilateral transtibial amputation following major limb trauma regardless of when the injury occurred
  • The injury and its treatment must meet the following criteria:

    • The residual fibula is not fractured or if fractured, is stabilized by internal fixation allowing for either the Ertl or Burgess procedure
    • Proximal tibia/fibula joint is stabilized
    • Soft tissue coverage allows for atypical closure and skin graft <100 cm2
    • Amputation will result in a residual limb that is ≥10 cm from joint line to end of tibia
  • Ages 18 and 60 inclusive

Exclusion Criteria:

  • At time of consent, patient has a Glasgow Coma Scale (GCS) motor score of 0-4 or a GCS motor score of 5 with a significant traumatic brain injury (defined as an AIS code of 5 or 6)
  • Patients with wound closure requiring a free tissue transfer
  • Fibula fractures proximal to the tibial bone cut that cannot be stabilized
  • Late amputation with presence of one of the following conditions: (i) infection within the zone of injury; (ii) chronic regional pain syndrome; (iii) post-traumatic thrombophlebitis
  • Patient has a spinal cord deficit
  • Patient has a previous leg or foot amputation or is non-ambulatory pre-injury
  • Patient has third degree burns on >10% total surface area affecting the study limb
  • Patient has a documented psychiatric disorder
  • Patient is unable to speak either English or Spanish
  • Severe problems with maintaining follow-up (e.g. patients who are prisoners or homeless at the time of injury or who are intellectually challenged without adequate family support).
  • Patient has an amputation to one or both upper extremities (excluding digits)
  • Patient is outside hospital's catchment area
  • Patient follow-up is planned at another medical center

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Ertl Procedure
Patients randomized to the Ertl Procedure Arm will receive an amputation very similar to the Burgess Procedure, except the surgeon will perform an additional step to make the cut end of the tibia bone heal to the cut end of the fibula bone with a bone bridge. This bone bridge connects the two bones together.
Active Comparator: Burgess Procedure
Patients randomized to the Burgess Procedure Arm will receive a below the knee amputation where the bone is cut and skin and muscle from the back of the leg are rotated to cover the cut end of your bone. This provides good soft tissue padding to the bone and a good shape to the leg for later fitting of your prosthesis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Reported Function
Time Frame: 18 Months
Patient reported function as measured using the Short Form Musculoskeletal Assessment (SMFA) 18 months following amputation
18 Months
Number of Revision Surgeries
Time Frame: 18 Months
Number of revision surgeries to the amputated limb within 18 months after the first amputation
18 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Impairment
Time Frame: 18 Months
Physical impairment will be determined using objective performance measures of agility (4 step square test and Illinois Agility Test), strength and power (sit-to-stand test and timed stair climb), speed (self-selected walking speed and 40 yard shuttle run), postural stability (single leg stance) and overall activity measured using the Step Watch activity monitor
18 Months
Treatment Costs
Time Frame: 18 Months
Initial hospitalization and overall treatment costs as determined from hospitals bills and data on utilization of outpatient health services
18 Months
Self Reported Pain
Time Frame: 18 Months
Pain measured using the Brief Pain Inventory (BPI) questionnaire
18 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Lisa Reider, MHS, PhD, Johns Hopkins University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Actual)

March 1, 2020

Study Completion (Actual)

March 1, 2020

Study Registration Dates

First Submitted

March 27, 2013

First Submitted That Met QC Criteria

March 27, 2013

First Posted (Estimated)

April 1, 2013

Study Record Updates

Last Update Posted (Actual)

May 26, 2026

Last Update Submitted That Met QC Criteria

May 21, 2026

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • W8XWH-10-2-0090

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transtibial Amputation

Clinical Trials on Ertl Procedure

Subscribe